Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

Name: Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
License: Public Domain

Providence Health & Services

ClinicalTrials.gov · Datasets · License: Public Domain

breast neoplasm female, breast cancer, breast carcinoma, breast tumor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 346907
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.